Antipsychotic Drugs Market Size, Share & Trends Report

Antipsychotic Drugs Market Size, Share & Trends Analysis Report By Disease (Schizophrenia, Bipolar Disorder), By Drug, By Therapeutic Class, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-1-68038-408-6
Number of Report Pages: 100
Format: PDF, Horizon Databook

Historical Range: 2018 - 2022
Forecast Period: 2024 - 2030
Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
  1.1. Market Segmentation and Scope
  1.2. Market Definitions
  1.3. Research Methodology
  1.3.1. Information Procurement
  1.3.2. Information or Data Analysis
  1.3.3. Market Formulation & Data Visualization
  1.3.4. Data Validation & Publishing
  1.4. Research Scope and Assumptions
  1.4.1. List of Data Sources
Chapter 2. Executive Summary
  2.1. Market Outlook
  2.2. Segment Outlook
  2.3. Competitive Insights
Chapter 3. Antipsychotic Drugs Market Variables, Trends, & Scope
  3.1. Market Introduction/Lineage Outlook
  3.2. Market Size and Growth Prospects (USD Million)
  3.3. Market Dynamics
  3.3.1. Market Drivers Analysis
  3.3.2. Market Restraints Analysis
  3.4. Antipsychotic Drugs Market Analysis Tools
  3.4.1. Porter’s Analysis
  3.4.1.1. Bargaining power of the suppliers
  3.4.1.2. Bargaining power of the buyers
  3.4.1.3. Threats of substitution
  3.4.1.4. Threats from new entrants
  3.4.1.5. Competitive rivalry
  3.4.2. PESTEL Analysis
  3.4.2.1. Political landscape
  3.4.2.2. Economic and Social landscape
  3.4.2.3. Technological landscape
  3.4.2.4. Environmental landscape
  3.4.2.5. Legal landscape
Chapter 4. Antipsychotic Drugs Market: Disease Estimates & Trend Analysis
  4.1. Segment Dashboard
  4.2. Antipsychotic Drugs Market: Disease Movement Analysis, 2023 & 2030 (USD Million)
  4.3. Schizophrenia
  4.3.1. Schizophrenia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.4. Bipolar Disorder
  4.4.1. Bipolar Disorder Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.5. Unipolar Disorder
  4.5.1. Unipolar Disorder Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.6. Dementia
  4.6.1. Dementia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.7. Others
  4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Antipsychotic Drugs Market: Drug Estimates & Trend Analysis
  5.1. Segment Dashboard
  5.2. Antipsychotic Drugs Market: Drug Movement Analysis, 2023 & 2030 (USD Million)
  5.3. Risperidone
  5.3.1. Risperidone Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.4. Quetiapine
  5.4.1. Quetiapine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.5. Olanzapine
  5.5.1. Olanzapine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.6. Aripiprazole
  5.6.1. Aripiprazole Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.7. Brexpiprazole
  5.7.1. Brexpiprazole Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.8. Paliperidone Palmitate
  5.8.1. Paliperidone Palmitate Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.9. Others
  5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Antipsychotic Drugs Market: Therapeutic Class Estimates & Trend Analysis
  6.1. Segment Dashboard
  6.2. Antipsychotic Drugs Market: Therapeutic Class Movement Analysis, 2023 & 2030 (USD Million)
  6.3. First Generation
  6.3.1. First Generation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.4. Second Generation
  6.4.1. Second Generation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.5. Third Generation
  6.5.1. Third Generation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Antipsychotic Drugs Market: Distribution Channel Estimates & Trend Analysis
  7.1. Segment Dashboard
  7.2. Antipsychotic Drugs Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Million)
  7.3. Hospital Pharmacies
  7.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4. Retail Pharmacies
  7.4.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.5. Online Pharmacies
  7.5.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Antipsychotic Drugs Market: Regional Estimates & Trend Analysis
  8.1. Antipsychotic Drugs Market Share, By Region, 2023 & 2030 (USD Million)
  8.2. North America
  8.2.1. North America Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.2.2. U.S.
  8.2.2.1. U.S. Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.2.3. Canada
  8.2.3.1. Canada Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.2.4. Mexico
  8.2.4.1. Mexico Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.3. Europe
  8.3.1. Europe Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.3.2. U.K.
  8.3.2.1. U.K. Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.3.3. Germany
  8.3.3.1. Germany Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.3.4. France
  8.3.4.1. France Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.3.5. Italy
  8.3.5.1. Italy Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.3.6. Spain
  8.3.6.1. Spain Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.3.7. Denmark
  8.3.7.1. Denmark Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.3.8. Sweden
  8.3.8.1. Sweden Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.3.9. Norway
  8.3.9.1. Norway Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.4. Asia Pacific
  8.4.1. Asia Pacific Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.4.2. China
  8.4.2.1. China Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.4.3. Japan
  8.4.3.1. Japan Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.4.4. India
  8.4.4.1. India Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.4.5. Australia
  8.4.5.1. Australia Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.4.6. South Korea
  8.4.6.1. South Korea Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.4.7. Thailand
  8.4.7.1. Thailand Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.5. Latin America
  8.5.1. Latin America Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.5.2. Brazil
  8.5.2.1. Brazil Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.5.3. Argentina
  8.5.3.1. Argentina Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.6. Middle East and Africa
  8.6.1. Middle East and Africa Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.6.2. Saudi Arabia
  8.6.2.1. Saudi Arabia Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.6.3. UAE
  8.6.3.1. UAE Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.6.4. South Africa
  8.6.4.1. South Africa Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.6.5. Kuwait
  8.6.5.1. Kuwait Antipsychotic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
  9.1. Recent Developments & Impact Analysis by Key Market Participants
  9.2. Company Categorization
  9.3. Company Heat Map Analysis
  9.4. Company Profiles
  9.4.1. H.Lundbeck A/S
  9.4.1.1. Participant’s Overview
  9.4.1.2. Financial Performance
  9.4.1.3. Product Benchmarking
  9.4.1.4. Recent Developments/ Strategic Initiatives
  9.4.2. Otsuka Pharmaceutical Co., Ltd.
  9.4.2.1. Participant’s Overview
  9.4.2.2. Financial Performance
  9.4.2.3. Product Benchmarking
  9.4.2.4. Recent Developments/ Strategic Initiatives
  9.4.3. Janssen Global Services, LLC
  9.4.3.1. Participant’s Overview
  9.4.3.2. Financial Performance
  9.4.3.3. Product Benchmarking
  9.4.3.4. Recent Developments/ Strategic Initiatives
  9.4.4. Eli Lilly and Company
  9.4.4.1. Participant’s Overview
  9.4.4.2. Financial Performance
  9.4.4.3. Product Benchmarking
  9.4.4.4. Recent Developments/ Strategic Initiatives
  9.4.5. AbbVie, Inc.
  9.4.5.1. Participant’s Overview
  9.4.5.2. Financial Performance
  9.4.5.3. Product Benchmarking
  9.4.5.4. Recent Developments/ Strategic Initiatives
  9.4.6. Teva Pharmaceutical Industries Ltd.
  9.4.6.1. Participant’s Overview
  9.4.6.2. Financial Performance
  9.4.6.3. Product Benchmarking
  9.4.6.4. Recent Developments/ Strategic Initiatives
  9.4.7. Dr. Reddy’s Laboratories Ltd.
  9.4.7.1. Participant’s Overview
  9.4.7.2. Financial Performance
  9.4.7.3. Product Benchmarking
  9.4.7.4. Recent Developments/ Strategic Initiatives
  9.4.8. Sumitomo Pharma
  9.4.8.1. Participant’s Overview
  9.4.8.2. Financial Performance
  9.4.8.3. Product Benchmarking
  9.4.8.4. Recent Developments/ Strategic Initiatives
  9.4.9. Alkermes
  9.4.9.1. Participant’s Overview
  9.4.9.2. Financial Performance
  9.4.9.3. Product Benchmarking
  9.4.9.4. Recent Developments/ Strategic Initiatives
  9.4.10. Bristol-Myers Squibb Company
  9.4.10.1. Participant’s Overview
  9.4.10.2. Financial Performance
  9.4.10.3. Product Benchmarking
  9.4.10.4. Recent Developments/ Strategic Initiatives

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.